Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of Intravaginal Products, LCFA-01 and LC103, for Bacterial Vaginosis Treatment

NCT07875673 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07875673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07875673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of Intravaginal Products, LCFA-01 and LC103, for Bacterial Vaginosis Treatment
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
February 3, 2027
Completion date
May 20, 2028
Enrollment
280 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis